Literature DB >> 29019082

Loss of the nutrient sensor TAS1R3 leads to reduced bone resorption.

Michael S Eaton1, Nicholas Weinstein1, Jordan B Newby1,2, Maggie M Plattes3, Hanna E Foster3, Jon W Arthur1, Taylor D Ward1, Stephen R Shively1, Ryann Shor4, Justin Nathan4, Hannah M Davis5, Lilian I Plotkin5,6, Eric M Wauson7, Brian J Dewar3, Aaron Broege4, Jonathan W Lowery8.   

Abstract

The taste receptor type 1 (TAS1R) family of heterotrimeric G protein-coupled receptors participates in monitoring energy and nutrient status. TAS1R member 3 (TAS1R3) is a bi-functional protein that recognizes amino acids such as L-glycine and L-glutamate or sweet molecules such as sucrose and fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that deletion of TAS1R3 expression in Tas1R3 mutant mice leads to increased cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness of cortical bone in femurs of 20-week-old male Tas1R3 mutant mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal cells (BMSCs) in vitro and its expression is maintained during BMP2-induced osteogenic differentiation. However, levels of the bone formation marker procollagen type I N-terminal propeptide (PINP) are unchanged in the serum of 20-week-old Tas1R3 mutant mice as compared to controls. In contrast, levels of the bone resorption marker collagen type I C-telopeptide are reduced greater than 60% in Tas1R3 mutant mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in Tas1R3 mutant mice is due to uncoupled bone remodeling with reduced osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in postnatal bone remodeling.

Entities:  

Keywords:  Bone; Osteoblast; Osteoclast; TAS1R1; TAS1R2; TAS1R3; Taste receptor

Mesh:

Substances:

Year:  2017        PMID: 29019082     DOI: 10.1007/s13105-017-0596-7

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  19 in total

1.  BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.

Authors:  Shoichiro Kokabu; Laura Gamer; Karen Cox; Jonathan Lowery; Kunikazu Tsuji; Regina Raz; Aris Economides; Takenobu Katagiri; Vicki Rosen
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  From small sweeteners to sweet proteins: anatomy of the binding sites of the human T1R2_T1R3 receptor.

Authors:  Gabriella Morini; Angela Bassoli; Piero A Temussi
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

3.  Bisphosphonates for osteoporosis--where do we go from here?

Authors:  Marcea Whitaker; Jia Guo; Theresa Kehoe; George Benson
Journal:  N Engl J Med       Date:  2012-05-09       Impact factor: 91.245

4.  High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.

Authors:  Rafael Pacheco-Costa; Iraj Hassan; Rejane D Reginato; Hannah M Davis; Angela Bruzzaniti; Matthew R Allen; Lilian I Plotkin
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

5.  Structure of the ternary signaling complex of a TGF-beta superfamily member.

Authors:  George P Allendorph; Wylie W Vale; Senyon Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

6.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.

Authors:  Kai Heinecke; Axel Seher; Werner Schmitz; Thomas D Mueller; Walter Sebald; Joachim Nickel
Journal:  BMC Biol       Date:  2009-09-07       Impact factor: 7.431

7.  Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.

Authors:  Binbin Li; Shifeng Yu
Journal:  Biol Pharm Bull       Date:  2003-06       Impact factor: 2.233

Review 8.  Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  David W Dempster; Juliet E Compston; Marc K Drezner; Francis H Glorieux; John A Kanis; Hartmut Malluche; Pierre J Meunier; Susan M Ott; Robert R Recker; A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

9.  Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities.

Authors:  Stephen P Berasi; Usha Varadarajan; Joanne Archambault; Michael Cain; Tatyana A Souza; Abe Abouzeid; Jian Li; Christopher T Brown; Andrew J Dorner; Howard J Seeherman; Scott A Jelinsky
Journal:  Growth Factors       Date:  2011-06-27       Impact factor: 2.511

Review 10.  Functional roles of the sweet taste receptor in oral and extraoral tissues.

Authors:  Anni Laffitte; Fabrice Neiers; Loïc Briand
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-07       Impact factor: 4.294

View more
  4 in total

1.  Loss of the nutrient receptor Tas1R3 reduces atherosclerotic plaque accumulation and hepatic steatosis in ApoE-/- mice.

Authors:  Shayla S Shojaat; Samuel Engman; Jason Hofferber; Faithe Keomanivong; Eric M Wauson
Journal:  J Physiol Biochem       Date:  2020-10-09       Impact factor: 4.158

Review 2.  Amino acids as signaling molecules modulating bone turnover.

Authors:  Ke-Hong Ding; Michael Cain; Michael Davis; Clare Bergson; Meghan McGee-Lawrence; Crystal Perkins; Trevor Hardigan; Xingming Shi; Qing Zhong; Jianrui Xu; Wendy B Bollag; William Hill; Mohammed Elsalanty; Monte Hunter; Maria C Isales; Patricia Lopez; Mark Hamrick; Carlos M Isales
Journal:  Bone       Date:  2018-02-27       Impact factor: 4.398

Review 3.  The role of GPCRs in bone diseases and dysfunctions.

Authors:  Jian Luo; Peng Sun; Stefan Siwko; Mingyao Liu; Jianru Xiao
Journal:  Bone Res       Date:  2019-07-08       Impact factor: 13.567

4.  Sweet taste receptor agonists attenuate macrophage IL-1β expression and eosinophilic inflammation linked to autophagy deficiency in myeloid cells.

Authors:  Jinju Lee; So Jeong Kim; Go Eun Choi; Eunbi Yi; Hyo Jin Park; Woo Seon Choi; Yong Ju Jang; Hun Sik Kim
Journal:  Clin Transl Med       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.